Health & bio

Ozempic may preserve lean mass better than Mounjaro

Healthline reported semaglutide (Ozempic) shows potential advantage over tirzepatide (Mounjaro) in lean mass preservation, though part of the difference stems from tirzepatide's larger weight loss magnitude.

Primary sources · 1
← View the full 2026-04-06 (Mon) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →